Grupo Gallego de Investigacions Oncológicas
GIO
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (8)
2022
2020
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Lat-1 and glut-1 carrier expression and its prognostic value in gastroenteropancreatic neuroendocrine tumors
Cancers, Vol. 12, Núm. 10, pp. 1-18
2019
-
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study
BMJ Open, Vol. 9, Núm. 5
-
Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry
Leukemia and Lymphoma, Vol. 60, Núm. 11, pp. 2720-2732
2015
-
Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation
Haematologica, Vol. 100, Núm. 5, pp. e200-e203
2011
-
Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: Prevalence, evolution of hormone dysfunction and genetic analysis
Neuroendocrinology, Vol. 93, Núm. 3, pp. 181-188
2009
-
Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert's syndrome
European Journal of Endocrinology, Vol. 160, Núm. 5, pp. 869-872